No evidence to suggest swine flu virus has mutated: NIV

Image
IANS New Delhi
Last Updated : Mar 12 2015 | 7:57 PM IST

The National Institute of Virology on Thursday said there was no evidence to suggest that the swine flu virus in India may have mutated.

A study by the Massachusetts Institute of Technology (MIT) conducted by a team of Indian-origin scientists said swine flu has killed over 1,500 people and infected more than 27,000 people in India and the virus has acquired mutations that make it more dangerous than previously circulating strains of H1N1 influenza.

The flu virus in India seems to have acquired mutations that could spread more readily, the MIT scientists warned in the study.

Official sources at the NIV in Pune said the genetic analysis of the H1N1 isolates from the present 2015 outbreak do not show any such mutations as mentioned in the MIT publication.

The observation in the MIT report was based on gene sequence analysed for the H1N1 virus taken from a database and not from actual virus isolates from the current 2015 outbreak, the NIV sources said.

The NIV works under the auspices of the Indian Council of Medical Research, the premier research organisation under the union health ministry.

Indian health experts also said the report needs to be studied thoroughly before being accepted.

"This is a new study. We need to go through it and research properly. It is important to know how they reached the conclusion. It will take at least one-two days to go through the study, only then I can comment on it," S.K. Sharma, director health services under the Delhi government, told IANS.

The findings, reported in the scientific journal Cell Host and Microbe, contradict previous reports from Indian health officials that the strain has not changed from the version of H1N1 that emerged in 2009 and has been circulating around the world ever since.

Mutation is a permanent change of the nucleotide sequence of the genome of an organism, virus, or extra-chromosomal DNA or other genetic elements.

N.K. Mehra, former dean of research at the All India Institute of Medical Sciences (AIIMS), said it was important to study the MIT report before coming to any conclusion.

"It will be too early to comment now without going through the report properly," he said.

A senior official of the health ministry also said the issue will be discussed with the Indian Council of Medical Research (ICMR) before coming to any conclusion.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 12 2015 | 7:50 PM IST

Next Story